Clinical Trials Logo

Tubular Breast Cancer clinical trials

View clinical trials related to Tubular Breast Cancer.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02221999 Active, not recruiting - Clinical trials for Inflammatory Breast Cancer

Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients

SHPD002
Start date: September 2013
Phase: Phase 2/Phase 3
Study type: Interventional

The investigators hypothesize that paclitaxel combined with cisplatin in a weekly-based regimen as neoadjuvant chemotherapy is effective and tolerable for locally advanced breast cancer. In patients with some sub-type advanced breast cancer, neo-adjuvant chemotherapy combined with endocrine therapy may improve the pathological remission rate. Premenopausal patients with triple negative breast caner and hormonal receptor positve breast cancer patients will be randominzed to have neoadjuvant chemotherapy combined with endocrine therapy or not.